Agoracom Blog

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:10 AM on Saturday, July 17th, 2021

A weekly summary of Novamind news and media, including the announcement of Novamind’s selection as a research site for Bionomics’ PTSD clinical trial.

OPINION July 7, 2021

Is the Mystical Experience Necessary for Psychedelic Healing?

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Reid Robison, Dr. Steve Thayer, and Derick Moody, PA-C discuss whether or not the mystical experience caused by many psychedelic medicines is a necessary factor for the healing they promote.

FEATURES July 7, 2021

The Future of Ketamine

Microdose covers ketamine’s history as an off-label treatment for depression, the FDA approval of Spravatoᵀᴹ (esketamine) and what the future looks like for these drugs. CEO Yaron Conforti and CMO Dr. Reid Robison were both interviewed for the article.

“Cost and accessibility are universal challenges we face in our healthcare system, and these will also apply to psilocybin, MDMA, and nearly every drug that comes to market, at least during the initial years of patent exclusivity,” said Robison.

View all media

Novamind Selected as Research Site for Bionomics’ PTSD Clinical Trial

We are pleased to announce that our wholly owned subsidiary, Cedar Clinical Research has been selected as a research site for a study titled “A phase IIb, randomized, double blind, two arm study to investigate the effects of BNC210 tablet formulation compared to placebo in adults with post-traumatic stress disorder”.

“This clinical trial leverages CCR’s established track record studying novel treatments for PTSD and other difficult to treat mental health conditions.” said Dr. Reid Robison, Chief Medical Officer of Novamind.

July 8, 2021

View all press releases

Psychedelic Drug Psilocybin “Magic Mushrooms” Spurs Growth of Neural Connections Lost in Depression

Larger and stronger neural connections. According to new research out of Yale, it’s all about the increased density of dendritic spines. “Small protrusions found on nerve cells which aid in the transmission of information between neurons. Chronic stress and depression are known to reduce the number of these neuronal connections.” If psilocybin can create larger and stronger neural connections, the potential for treating depression and creating lasting change improves significantly. 

Can LSD Treat Food Allergies? We Don’t Know, But It’s Already Been Patented

While “there have been no research studies in humans showing that LSD can treat allergies of any kind” one patent application hopes that one day LSD will be able to treat food allergies. The article references a story about a claim (not research- or evidence-based) that LSD cured a lifelong cat allergy and goes into more detail about the patent process and what might stand in the way of this one getting approved. “It’s based on luck.” And it’s another entrant to the race to patent psychedelics.

Follow @novamind_inc on Instagram

For further information, contact:

Bill Mitoulas
Investor Relations
Telephone: +1 (416) 479 9547
Email: [email protected]

VIDEO – With $17M In Profitable Cannabis Revenues Already, The Latest Kiaro Acquisitions Are Expected To Create $43M In Revenue & $13.7M Gross Profit

Posted by AGORACOM-JC at 4:54 PM on Friday, July 16th, 2021
Kiaro holdings corp  kiaro completes kelowna cannabis retail loc

Kiaro Holdings is an multi-channel cannabis retailer and distributor with existing storefronts across British Columbia , Saskatchewan and Ontario, a wholesale distribution servicing Saskatchewan and ecommerce sites in Canada , the US and Australia, which have resulted in the following:

  • ANNUAL REVENUE              $17.1M Up 230%
  • ANNUAL GROSS PROFIT     $5.1M Up 281%  
  • Q1 REVENUE                          $5.2M Up 94%
  • Q1 GROSS PROFIT                 $1.56M Up 118%

But CEO Daniel Petrov and his team of retail winners aren’t stopping there. On July 13th, $KO announced  Kiaro Acquires Hemisphere Cannabis and Adds 7 Retail and 2 Development Locations in Ontario To Become a Prominent National Cannabis Retailer with Forecasted Annual Revenues of $42.7 Million.

If you believe in the long-term future of the cannabis market, then you have to discover KIARO by watching our first ever interview with CEO Daniel Petrov.

VIDEO – FOBI AI Anticipated Major Deals, Revenues and Partnerships In 2021 Set The Table For Uplisting To Major Exchange By Q4

Posted by AGORACOM-JC at 4:10 PM on Friday, July 16th, 2021
Fobi AI Inc.

FOBI AI is a global leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement for enterprise level retailers. 

More than just lip service, these are just a sample of the major milestones reached by $FOBI over the past 9 months: 

  • Strategic Alliance with global data leader – NeilsonIQ – to “Transform Retail Sector”
  • A partnership with NTT DATA, a top-ranked global IoT services company, and subsidiary of Nippon Telegraph and Telephone, the world’s 4th largest telecom company, ranked 55th In Fortune Global 500. 
  •  Approved for Oracle Partner Network
  • Pilot Projects with Sobeys, TELUS, Certas and other national level retailers
  • Multi-Year Direct Seller Agreement With TELUS, in which TELUS resells FOBI solutions to national business customers
  • …. and so much more

Earlier today, $FOBI announced a Corporate Update Includes Completion Of Several Pilot Tests Now In Advanced Terms Negotiations, $10.42M in Funding And Uplist To Major Exchange.

Investors who were excited by the announcement may have even further cause to celebrate following this interview with CEO Rob Anson.

VIDEO: Fabled Silver Gold Goes “Beyond The Presentation” with New High Grade Gold Discovery in Mexico $FCO $FBSGF $RDU $KTN $GMBXF $EDR

Posted by AGORACOM at 4:35 PM on Thursday, July 15th, 2021

Fabled Silver Gold (FCO TSXV) ( FBSGF: OTC ) controls 100% of the Santa Maria mine gold and silver property in Mexico. It is a high grade silver gold property that is situated right in the middle of the Mexican Epithermal silver gold belt that has reportedly produced more silver than any other equivalent area in the entire planet.

To say it’s a mining friendly jurisdiction is an understatement.

Multiple major operators are in the vicinity and it’s already got a silver equivalent 43-101 of 3.2m ounces, but is looking to add to that significantly with recent intercepts of 2269 g/t silver.

That is not a typo, in other words it is also 2.269 kilos AgEq or 72 troy ounce.

Just recently, Fabled encountered a new, previously unknown gold zone with the discovery of a new high grade gold system with values up 10.85 g/t Au within 30.7m grading 161.09 Ag Eq

This quote from Peter J. Hawley, CEO and President sums up the future potential aptly:

……“ we have found a new, never discovered high grade gold mineral domain system, with silver credits, over consistent widths in an area never explored, and which remains open to the west and at depth, plunging 45 degrees to the west and open in all directions for expansion.

Recent underground diamond drilling also intercepted 4 Zones of Silver Mineralization including 314.35 g/t Ag Eq over 0.80m.

Fabled is intent on proving Santa Maria is bigger and of potentially higher grade than the market understands and is well on its way with intercepts such as these.

Sit back with your favorite beverage as Peter Hawley explains the importance of the latest discovery within the context of the Fabled corporate presentation

The Santa Maria Project is poised to deliver as exploration continues to deliver discoveries through both above and underground drill programs.

VIDEO – PyroGenesis Plasma Torch Technology Is Providing Greenhouse Gas Reductions and Cost Efficiencies Across Major Global Verticals

Posted by AGORACOM-JC at 5:47 PM on Tuesday, July 13th, 2021

PyroGenesis is the world leader in the development of advanced plasma processes and products.  In short, their plasma torch technology has been the foundation of multiple successful applications around the world that significantly reduce both greenhouse gases and costs of doing business for some of the world’s biggest companies in these following verticals: 

  • Ultra High-Tech 3D Printing (Additive Manufacturing)
  • Iron Ore Pelletization
  • Aluminum Smelters Recovery Of Dross
  • High-Purity Silicon For EV Batteries
  • ….. More

Today, PyroGenesis CEO Peter Pascali provides investors with a comprehensive update of each vertical and some of the major business developments taking place within each of them.
Watch our great interview with CEO Peter Pascali 

VIDEO – Universal PropTech (UPI: TSXV) (UPIPF: OTCQB) Talks Growing Backlog At ~ $6 Million, Organic Growth, Tier-1 Customers and More

Posted by AGORACOM-JC at 4:06 PM on Monday, July 12th, 2021
This image has an empty alt attribute; its file name is SMS-Smalljpg-1.jpg

As the name implies “PropTech” is a combination of two words and stands for “property technology.”  As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing paradigm shift, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada. 

More than just lip service, UPI clients include:

· Federal Government facilities for over 40 years 

· Manulife 

· Brookfield 

· Billy Bishop Airport 

· University of Toronto 

· …. and many more 

The company’s backlog is now a staggering $~6 million.

This represents:

  • + $800,000 from April
  • + $3,000,000 swing from September

This is comprised of awarded and not executed work, made up of a combination of service contracts and project work in both HVAC Building Automation and Mechanical lines of business.

We sat down with Frank Carnevale, CGO of Universal Proptech, to talk about their multimillion-dollar backlog. Check out the full interview below.

VIDEO – HealthSpace Data Systems $HS.ca $HDSLF Aims to Redefine Government Efficiency with Explosive Growth & New Contracts

Posted by AGORACOM at 2:26 PM on Saturday, July 10th, 2021
HealthSpace HS 300 x 300

If there is one thing we know about governments – whether it’s at the local, state, or federal level – it is that they can be hugely inefficient.

HealthSpace Data Systems’ (CSE: HS) (OTCQB: HDSLF) (Frankfurt: 38H) “empowering government efficiency” solution has led the firm to become an industry leading tech pioneer, providing both enterprise- and mobile internet-based applications to more than 500 state and local government organizations in North America, including in California, Missouri, Illinois, Wisconsin and Ontario.

In April, HealthSpace launched GovCall, a teleconferencing platform focused exclusively on the government market. The company now offers the only integrated product suite that incorporates inspection, administration and analytics across all platforms in North America.

  • cloud-based and mobile platform helps revolutionize every aspect of government regulatory work
  • including licensing and inspections, accounting, even disease surveillance

The company continues to go from strength to strength. Last month, CEO Silas Garrison presented a sizable corporate update, outlining:

  • a strong start to the year: US$3.8M in new deals in Q1 2021 and US$5.6M in deals since the year’s start
  • Anticipate achieving US$8M in ARR under contract within the next 6-9 months.
  • This past December $HS raised more than CAD$6M million in equity. 
  • Will be used to deal with more aggressive R&D and feature development strategies, as well as handle the increasing volume of customers
  • $HS has doubled the number of team members over the last 9 months, with over 30 new hires, and has 74 full-time team members today
  • Paul Victor joined as our Head of Engineering in March
  • Chirag Bhatt joined the team in May as Director of Regulatory Affairs for Environmental Health. 
  • The total pipeline of deals stands at over US$22M, expected to close over the next 12-18 months.
  • Since last corporate update in Nov 2020, $HS has converted approximately US$7.3m of the pipeline to either signed or contract awards. 
  • Annualized, this is an 80% conversion rate from the pipeline (contract numbers, not by dollars).  As of today, the pipeline represents the addition of US$6.8M in new deals added to the pipeline in 2021.
  • The deals in this pipeline are of all sizes, ranging from US$9,000 to over US$5m.

We sat down with him to talk through the company’s progress and look ahead to 2022 and beyond.  

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:19 AM on Saturday, July 10th, 2021

A weekly summary of Novamind news and media, including the announcement of Novamind’s selection as a research site for Bionomics’ PTSD clinical trial.

OPINION July 7, 2021

Is the Mystical Experience Necessary for Psychedelic Healing?

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Reid Robison, Dr. Steve Thayer, and Derick Moody, PA-C discuss whether or not the mystical experience caused by many psychedelic medicines is a necessary factor for the healing they promote.

FEATURES July 7, 2021

The Future of Ketamine

Microdose covers ketamine’s history as an off-label treatment for depression, the FDA approval of Spravatoᵀᴹ (esketamine) and what the future looks like for these drugs. CEO Yaron Conforti and CMO Dr. Reid Robison were both interviewed for the article.

“Cost and accessibility are universal challenges we face in our healthcare system, and these will also apply to psilocybin, MDMA, and nearly every drug that comes to market, at least during the initial years of patent exclusivity,” said Robison.

View all media

Novamind Selected as Research Site for Bionomics’ PTSD Clinical Trial

We are pleased to announce that our wholly owned subsidiary, Cedar Clinical Research has been selected as a research site for a study titled “A phase IIb, randomized, double blind, two arm study to investigate the effects of BNC210 tablet formulation compared to placebo in adults with post-traumatic stress disorder”.

“This clinical trial leverages CCR’s established track record studying novel treatments for PTSD and other difficult to treat mental health conditions.” said Dr. Reid Robison, Chief Medical Officer of Novamind.

July 8, 2021

View all press releases

Psychedelic Drug Psilocybin “Magic Mushrooms” Spurs Growth of Neural Connections Lost in Depression

Larger and stronger neural connections. According to new research out of Yale, it’s all about the increased density of dendritic spines. “Small protrusions found on nerve cells which aid in the transmission of information between neurons. Chronic stress and depression are known to reduce the number of these neuronal connections.” If psilocybin can create larger and stronger neural connections, the potential for treating depression and creating lasting change improves significantly. 

Can LSD Treat Food Allergies? We Don’t Know, But It’s Already Been Patented

While “there have been no research studies in humans showing that LSD can treat allergies of any kind” one patent application hopes that one day LSD will be able to treat food allergies. The article references a story about a claim (not research- or evidence-based) that LSD cured a lifelong cat allergy and goes into more detail about the patent process and what might stand in the way of this one getting approved. “It’s based on luck.” And it’s another entrant to the race to patent psychedelics.

Follow @novamind_inc on Instagram

 
 

For further information, contact:

Bill Mitoulas
Investor Relations
Telephone: +1 (416) 479 9547
Email: [email protected]

VIDEO – HPQ Silicon Ability To Create Cleanest Fumed Silica Has Company Already Fielding Calls From Silicon Players Around The World

Posted by AGORACOM-JC at 4:53 PM on Tuesday, July 6th, 2021

HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.

If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:

Recently, the Company announced a major milestone with this press release HPQ Silicon GEN3 PUREVAP™ Quartz Reduction Reactor Pilot Plant to be Commissioned in Q4 2021

To understand the importance and the implications of this milestone, this excerpt from the press release says it all:

” Demand for higher purity Silicon, materials that the PUREVAP QRR was designed to produce – but one that traditional silicon producers have a difficult time making, is about to enter a massive growth phase, driven by worldwide demand from the silicones, solar, and batteries industries. The Covid-19 pandemic accelerated the closing of old inefficient traditional Silicon plants and combining this with the chronic under investment in new conventional Silicon plants that occurred in the past decade, and the need for more efficient and environmentally friendly processes has created a perfect storm for the industry. HPQ should be a key beneficiary of this new reality.”

Today, thanks to HPQ’s great progress on its silicon mission, the Company announced  “An Agreement to Develop a New Environmentally Friendly Process to Manufacture Fumed Silica”
What is Fumed Silica?  Suffice it to say, it is in heavy demand right now but current producers are going to run into strong environmental “ESG” headwinds as the industry is now moving towards clean and verified Fumed Silica that HPQ Silicon believes it will be able to deliver thanks to its powerful relationship with ESG driven PyroGenesis Canada. The market for Fumed Silica is set to hit $USD 2.2 Billion in 2022 and CEO Tourillon wasn’t shy about his confidence in the Company’s potential to win market share with this quote:

““The business opportunity that this represent should not be underestimated and could be as significant as the ones represented by the PUREVAP™ family of processes we are developing with PyroGenesis”

Watch this great interview with $HPQ CEO Bernard Tourillon – especially the last 13 minutes – to get the full picture!

VIDEO – With 2020 Audit Complete, Empower Clinics CEO Steve McAuley Sees Big Growth For Operations, US Expansion, Market Cap & Uplisting

Posted by AGORACOM-JC at 6:17 PM on Monday, July 5th, 2021

With $US 3.2M in 2020 revenue, representing a 58% increase over the previous year, you would think Empower Clinics CEO Steve McAuley would use his first interview after the filing to celebrate. 

He isn’t. 

Rather, with Fiscal 2020 having come to end more than 6 months ago, the 2020 results are a distant rear view mirror shot of a Company that is in full-blown growth mode and can be best summarized as follows: 

“Multiple opportunities have been percolating and I’m going to turn up the heat” 

To this end McAuley sees a “substantially higher market cap” for the Company, as well as, growth that will be “deserving of an uplist”. 

We could try to list all the powerful things he had to say in this interview – but best we let you watch/hear it straight from Steve in this amazing interview.